About OnCusp
OnCusp is a company based in New York (United States) founded in 2021.. OnCusp has raised $100 million across 1 funding round from investors including Marshall Wace, Orbimed and Novo Holdings. OnCusp offers products and services including CUSP06 and Pipeline Development. OnCusp operates in a competitive market with competitors including Helsinn, Aster Insights, Abogen Biosciences, CancerVax and Linical, among others.
- Headquarter New York, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$100 M (USD)
in 1 rounds
-
Latest Funding Round
$100 M (USD), Series A
Jan 04, 2024
-
Investors
Marshall Wace
& 9 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of OnCusp
OnCusp offers a comprehensive portfolio of products and services, including CUSP06 and Pipeline Development. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Drug targeting Platinum-Resistant Ovarian Cancer in clinical trials
Transforms molecules into innovative cancer therapeutics globally
Funding Insights of OnCusp
OnCusp has successfully raised a total of $100M through 1 strategic funding round. The most recent funding activity was a Series A round of $100 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $100.0M
-
First Round
First Round
(04 Jan 2024)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2024 | Amount | Series A - OnCusp | Valuation | Novo Holdings , Orbimed |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in OnCusp
OnCusp has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Marshall Wace, Orbimed and Novo Holdings. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and venture capital fund focused on the healthcare sector
|
Founded Year | Domain | Location | |
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location | |
|
Investments in life sciences, technology, healthtech, and crypto sectors from global locations.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by OnCusp
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - OnCusp
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Oncusp Comparisons
Competitors of OnCusp
OnCusp operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helsinn, Aster Insights, Abogen Biosciences, CancerVax and Linical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Oncology therapeutics are developed, manufactured, and commercialized by Helsinn.
|
|
| domain | founded_year | HQ Location |
Contract-based oncology clinical trial services are provided by Aster Insights.
|
|
| domain | founded_year | HQ Location |
mRNA-based therapeutics are developed for cancer and infectious diseases.
|
|
| domain | founded_year | HQ Location |
Cancer vaccine research and development is conducted by CancerVax.
|
|
| domain | founded_year | HQ Location |
Full-service CRO operations are conducted across more than 20 countries.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Oncusp
Frequently Asked Questions about OnCusp
When was OnCusp founded?
OnCusp was founded in 2021 and raised its 1st funding round 3 years after it was founded.
Where is OnCusp located?
OnCusp is headquartered in New York, United States. It is registered at New York, New York, United States.
Is OnCusp a funded company?
OnCusp is a funded company, having raised a total of $100M across 1 funding round to date. The company's 1st funding round was a Series A of $100M, raised on Jan 04, 2024.
What does OnCusp do?
OnCusp cro offering clinical development services for oncology drugs through providing healthcare solutions, biopharma outsourcing, cro, clinical development, full service, and oncology. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Who are the top competitors of OnCusp?
What products or services does OnCusp offer?
OnCusp offers CUSP06 and Pipeline Development.
Who are OnCusp's investors?
OnCusp has 10 investors. Key investors include Marshall Wace, Orbimed, Novo Holdings, F-Prime Capital, and Sofinnova.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.